TCTR20240408001招募中不适用
Time to return driving after lower extremity fracture : A longitudinal study
Research unit , Faculty of medicine siriraj hospital0 个研究点目标入组 68 人开始时间: 2024年4月8日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •1. Patients with right lower extremity fracture status post fixation of right femoral or tibial fracture
- •Femoral shaft fracture ( AO 32 A1,A2,A3,B1B2,C1)
- •Distal femoral fracture ( AO 33 A1,A2,B1,B2 )
- •Tibial plateau fracture ( Schatzker I-IV , AO 41 A1,A2,B1,B2,B3,C1 )
- •Tibial shaft fracture ( AO 42 A1,A2,A3,B1,B2,C1)
- •Tibial plafond fracture ( AO 43 A1,A2,B1,B2,C1)
- •2. Age 18-70 years old
- •3. Follow-up at department of Orthopaedic Surgery, faculty of Medicine Siriraj Hospital
排除标准
- •1. Patients with history of recent fracture in right lower extremity within 3 months
- •2. Patients with multiple fractures in right lower extremity more than 1 location
- •3. Patient with functional dependence
- •4.Patients with medical unfit for driving
- •5. Patients with no secure fracture fixation construct for early weight bearing
研究者
相似试验
进行中（未招募）
1 期
ICADTS class III medication and fitness to driveEUCTR2013-004936-31-NLMinistry of Infrastructure and the Environment
已完成
4 期
Establish limits for fitness to drive with prolonged use of ICADTS class III medicatiodepressieve stemmingsstoornissen - en afwijkingenslaapstoornissen - en afwijkingensleeping problems10002861depressionanxietyNL-OMON41276Ministerie van Volkshuisvesting, Ruimtelijke Ordening en Milieu (VROM)272
尚未招募
1 期
Continuous Infusion Analgesia in Post Surgical Distal Radial FracturesACTRN12606000450516Dr Ryan Shulman40
招募中
不适用
Return to road traffic after operations on the knee joint. A prospective examinatiohealthy volunteersZ98.8M23Other specified postsurgical statesInternal derangement of kneeDRKS00023239Medizinische Hochschule Hannover90
已完成
不适用
Assessment of next-morning driving performance after middle of the night administration of zolpidem tartrate sublingual tablet 3.5 mg in healthy adult volunteers: single-center, double-blind, randomized, placebo-controlled, four-way crossover studyinsomniaNL-OMON34606Transcept Farmaceuticals, Inc40